1218 results found
Led by UNSW’s School of Women’s and Children’s Health Associate Professor Robert Gilchrist, an international team of researchers have improved an existing treatment known as in-vitro maturation (IVM).
Dietary change is a significant lifestyle factor in managing the epidemics of obesity and diabetes. Uncovering the details of effective dietary change requires accurate user friendly dietary assessment and advice tools.
The Direct Research Cost (DRC) Guidelines (Guidelines) set out the general principles that researchers, Research Administration Officers and Finance Officers should use to guide the appropriate allocation of NHMRC funds for salaries and stipends, and to determine whether expenses are DRCs for the NHMRC funded Research Activity.
Haemolytic disease of the fetus and newborn (HDFN, also known as Rh Disease) can occur during pregnancy when a pregnant woman’s immune system produces antibodies that attack their fetus’ red blood cells (RBCs). Once a major cause of fetal and newborn mortality, today HDFN is almost non-existent in Australia due to routine antenatal blood grouping and antibody screening, and the use of prophylactic Rh D immunoglobulin and appropriate clinical management of mother and baby. Guidelines, initially produced by NHMRC on behalf of the Department of Health and Ageing, have assisted with translation of the research on Rh D antibody screening and Rh D immunoglobin into clinical practice.
Leukaemia is the most diagnosed cancer in children and the second most common cancer causing death among children in Australia.1 NHMRC-funded researchers at the Children’s Cancer Institute (CCI), in collaboration with researchers at Flinders University and in European laboratories, developed a highly accurate and sensitive technique – known as minimal residual disease (MRD) testing – that enables doctors to improve anti-cancer treatment for children with the most common type of leukaemia.
NHMRC’s goal is to support the highest quality research that will lead to improvements in health over the short or long term. Peer review by independent experts is used to identify well-designed feasible projects that address a significant question and are undertaken by researchers with demonstrated capacity to perform high-quality research.
The National Health and Medical Research Council (NHMRC) are uniquely positioned to work with individuals, philanthropic trusts, foundations and other funders to help support health and medical research in Australia. Philanthropists interested in supporting high quality health and medical research projects are encouraged to review the opportunities for, and benefits of, engaging with us.
Until the 1970s, people experiencing infertility had few options. Commencing in the late 1960s, NHMRC-funded researchers at Monash University and other research centres in Melbourne began creating in vitro fertilisation (IVF) technologies and developed them into robust medical procedures that are now used worldwide. These technologies have significantly expanded the options available for those wishing to have a baby and today IVF is responsible for about 1 in 20 births in Australia.
In the final days of Professor Anne Kelso’s term at NHMRC, we are reflecting on changes that have taken place at the agency and in the wider sector while she has served as CEO. During an interview with Cate Swannell for the MJA Podcast on December 5 2022, Professor Kelso discussed some of the most significant experiences of her tenure, including the introduction of an initiative to address gender disparities in the Investigator Grant scheme.
The Embryo Research Licensing Committee (ERLC) of the National Health and Medical Research Council has considered whether specific embryo models fall within the regulation of the Research Involving Human Embryos Act 2002 and Prohibition of Human Cloning for Reproduction Act 2002. The information below is based on ERLC’s understanding of the science at the time it was considered.
Glaucoma is the leading cause of irreversible blindness worldwide, with an estimated 80 million people affected1 including more than 200,000 Australians.2 Over two decades, NHMRC-funded researchers at the Lions Eye Institute (LEI) and the University of Western Australia (UWA) developed a new approach that has revolutionised glaucoma treatment, leading to safer surgery and improved vision outcomes. With later support from an international industry team, this new glaucoma surgery is now in use worldwide.
During the mid-20th century, epidemics of hospital-based and antibiotic resistant Staphylococcus aureus – or golden staph – were causing serious illness and death in hospitals internationally, and one strain was a particular problem in maternity hospitals. NHMRC-funded bacteriologists working at the Royal Prince Alfred Hospital (RPA) in Sydney made important contributions to knowledge about how to identify strains of golden staph and how to control its spread.
Chronic Obstructive Pulmonary Disease (COPD) was the fifth leading cause of death in Australia in 2020. With early diagnosis and treatment, people with COPD can breathe better and live healthier lives.
Obstructive sleep apnea (OSA) is a chronic respiratory disorder that leads to disturbed sleep and causes sickness in at least 200 million people globally.1 In 2018–19, over 39,000 Australians were hospitalised with a principal diagnosis of OSA.2
Chronic cough is a common problem in children that impairs quality of life, with a burden often unappreciated by health professionals. Protracted Bacterial Bronchitis (PBB) is the most common cause of chronic cough in children. Untreated, it leads to poor future lung health outcomes such as bronchiectasis.
Road Map 3 is a comprehensive 10-year strategic framework to improve the health of Australia's Aboriginal and Torres Strait Islander population.